This programme is offered by the UCL Division of Medicine and the Wolfson Institute for Biomedical Research and is designed for the more research-oriented student, complementing Drug Design MSc. Conducting cutting-edge research within the drug industries and UCL's academic group, it offers opportunities for networking and future career development. This programme teaches students the latest methodologies and approaches and covers all aspects of drug design: drug discovery, computational and structural biology, screening, assay development, medicinal chemistry, and most importantly the industrial practices involved in modern drug design technology. The division hosts research groups in the areas of medicine, pharmaceutical research, cell cycle, neurobiology, mitochondrial function, stem cells and cancer. Underpinning the translational aspects of the biomedical research, we have a medicinal chemistry group which conducts research where chemistry and biology intersect, using the latest techniques and developing new ones for the study of biological systems. The division collaborates extensively within industry and academia to develop biological tools and therapeutic agents. There are plenty of opportunities to conduct translational research that has an impact on drug discovery. We expect students graduating from this programme to take leading roles in drug discovery and development worldwide or to undertake further PhD-level research. Drug Design MRes graduates have found jobs in the pharmaceutical industry as well as PhD studentships in leading universities.